Previous Episode: 73: Rasprava
Next Episode: 75: Magla

✓ Da li nas pojava omikron varijante vraća u mart 2020-e?
✓ Da li oni koji su preležali kovid mogu da preskoče vakcinu?
✓ Vredi li šta kineska vakcina?
Odgovor na sva tri pitanja je ne, ali ipak preslušajte.

✓ Da li nas pojava omikron varijante vraća u mart 2020-e?

✓ Da li oni koji su preležali kovid mogu da preskoče vakcinu?

✓ Vredi li šta kineska vakcina?

Odgovor na sva tri pitanja je ne, ali ipak preslušajte.

Links:

Coronavirus chart: see how your country compares | Free to read | Financial Times — Governments’ stark daily figures on the spread of coronavirus are difficult to compare across countries, and may be significant undercounts. But the data needed to analyse the more reliable and comparable excess mortality metric are only available in a few jurisdictions, leaving these official case and death counts the best available data for much of the world.What we know about Omicron variant that has sparked global alarm | Financial Times — Studies show emerging strain is more transmissible and has higher resistance to vaccines Webinar April 27, 2021 - Johnson & Johnson/Janssen COVID-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome (TTS): Update for Clinicians — This COCA Call will present the latest evidence on thrombosis with thrombocytopenia syndrome (TTS) after administration of the Johnson & Johnson/Janssen COVID-19 vaccine. Speakers will discuss information on TTS and updated vaccine recommendations.Clinical Considerations: Myocarditis after mRNA COVID-19 Vaccines | CDC — Since April 2021, increased cases of myocarditis and pericarditis have been reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna), particularly in adolescents and young adults. There has not been a similar reporting pattern observed after receipt of the Janssen COVID-19 Vaccine (Johnson & Johnson).